NFKB1 and classic Hodgkin lymphoma: Since the cHL patient described by Challenor and Tucker [2] tested positive for EBV, we assess in our second hypothesis that some SARS-CoV-2 proteins might inhibit the oncogenic signaling of LMP-1 by binding to its cytoplasmic signaling motif residues 204-208 aa/“PQQAT” and 379-384 aa/“PVQLSY” that recruit TRAFs and TRADD, respectively, to activate the oncogenic NF-kB signaling-induced B-cell proliferation [26].